Skip to search boxSkip to navigationSkip to main content

Temperature inactivation of Feline calicivirus vaccine strain FCV F-9 in comparison with human noroviruses using an RNA exposure assay and reverse transcribed quantitative real-time polymerase chain reaction-A novel method for predicting virus infectivity

  • J. R. Topping
    ,
  • H. Schnerr
    ,
  • J. Haines
    ,
  • M. Scott
    ,
  • M. J. Carter
    ,
  • M. M. Willcocks
*Corresponding author for this work
  • Leatherhead Food Research
    ,
  • University of Surrey
    ,
  • Unilever
Research Output:
Contribution to journal
Article
Research
Peer-review

Abstract

A one-step reverse transcription quantitative real-time polymerase chain reaction (RT-QPCR) method in combination with RNase treatment and low copy number samples was developed in order to examine the effect of temperature on the ability of virus capsids to protect their RNA content. The method was applied to a non-cultivable virus (GII.4 norovirus) and Feline calicivirus vaccine strain F-9 (FCV) which is often used as a norovirus surrogate. Results demonstrated that FCV RNA is exposed maximally after 2 min at 63.3 °C and this correlated with a greater than 4.5 log reduction in infectivity as assessed by plaque assay. In contrast human GII.4 norovirus RNA present in diluted clinical specimens was not exposed maximally until 76.6 °C, at least 13.3 °C greater than that for FCV. These data suggest that norovirus possesses greater thermostability than this commonly used surrogate. Further, these studies indicate that current food processing regimes for pasteurisation are insufficient to achieve inactivation of GII.4 NoVs. The method provides a novel molecular method for predicting virus infectivity.

Research Output Information

Output type

Research Output:
Contribution to journal
Article
Research
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 89-95 (7 pages)

Journal (Volume, Issue Number)

Journal of Virological Methods (Volume 156, Issue 1-2)

Publication milestones

  • Published - 03/2009

Publication status

Published - 03/2009

ISSN

0166-0934

Publication IDs

  • Scopus: 59949103437
  • PubMed: 19028524

Funding Details

The authors wish to thank Dr. S. Clegg for useful discussions. This work was supported under the Food LINK programme by the UK Department for Environment, Food and Rural Affairs (Defra) and by industrial support from Unilever plc, Waitrose plc, Princess Cruises plc, Atlas Genetics Ltd., Scottish Shellfish Marketing Group, Premier Foods Ltd., and Evans Vanodine plc, H.S. was a recipient of a Marie Curie Fellowship financed by the European Commission.
FundersFunding numbers
Atlas Genetics Ltd.
-
Evans Vanodine plc
-
Princess Cruises plc
-
Scottish Shellfish Marketing Group, Premier Foods Ltd.
-
Unilever plc, Waitrose plc
-
Defra
-
EC
-

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well